CFU vs. Survivability: What Your Probiotic Label Isn't Telling You
Every probiotic brand competes on CFU count. 10 billion. 40 billion. 100 billion. The numbers keep climbing, as if more automatically means better. But a bigger number does not tell you how many bacteria are still alive when you take the product, or how many survive digestion. That depends on the strain, the formulation and how the product is stored.
The more useful questions are how many live bacteria remain at the end of a product's shelf life, and whether the specific strains in it have been shown in studies to survive digestion and to do anything useful. These are different from the CFU count at manufacture, and the label does not always answer them.
What CFU Actually Means
CFU stands for Colony Forming Unit — a measure of how many viable, live bacteria are present in a sample. In theory, a higher CFU means more potential benefit. A probiotic is defined as live microorganisms that give a health benefit when taken in adequate amounts,[3] so the number matters, but what counts as adequate depends on the strain and the outcome studied. On many labels the CFU figure refers to the time of manufacture, not the time you take the capsule, and it does not show how many bacteria survive digestion.
There are two points where the number of live bacteria can fall before they reach the intestine:
Storage and shelf life
Many probiotic strains are sensitive to heat, moisture and oxygen. In a 12-month study of commercial multi-strain probiotic supplements, storage temperature was the main factor affecting viability: the greatest losses trended toward room-temperature storage, and refrigeration or freezing preserved counts better. Compliance with label-declared counts declined toward the end of the minimum durability period, and some products fell short of declared values regardless of storage.[2] Some labels say "40 billion CFU at time of manufacture" in small print; others state the count through the expiry date, which is the more informative figure. Check the storage instructions on the label.
Stomach acid transit
Stomach contents are strongly acidic, and bile salts add a further challenge in the intestine. For most bacteria given by mouth, passage through the stomach causes a large loss of viability, which lowers the likely effect of a supplement.[1] How much is lost varies by strain and formulation, so a single survival percentage cannot be applied to every product.
Arrival in the gut (or not)
Probiotic effects are thought to occur in the intestine, so survival through the stomach matters. But a higher CFU count does not guarantee a better result, and neither does a protective capsule: what matters is whether the specific strains, at the dose in the product, have been shown to survive and to produce a benefit in studies.
Survival through the stomach differs between strains and formulations, and figures from laboratory studies in simulated gastric fluid cannot be applied to a particular product. We did not find a verified figure for how many bacteria survive in standard capsules, so no percentage is given here. Label counts are also not always what is found in the product: one laboratory survey of marketed probiotic supplements sold in a single local market found that almost none met their label claims (results may not apply elsewhere),[4] and in the 12-month storage study described above, some products fell short of declared counts regardless of storage.[2]
MAKTREK® Bi-Pass Technology: What the Label Lists
The Kasivit Probiotic label lists MAKTREK® (Bi-Pass Technology) and a complex marine polysaccharide (60 mg per serving) among its ingredients. The manufacturer describes the technology as a protective matrix intended to help the bacteria survive stomach acid. We did not find any published study of MAKTREK® in PubMed, so no survival data for this product is cited here. Microencapsulation in a polymer matrix is one approach being studied to reduce the loss of viability, but the authors of a review of the field noted areas where studies have fallen short, and results depend on the strain and formulation.[1] Survival through the stomach for any product should be checked against its label and published strain-level studies.
The Four Strains: Why Strain-Level Detail Matters
Strain selection is the other half of the equation. "Probiotic" is a category, not a specific organism: there are hundreds of strains, and their effects are strain-specific. The effects seen with one strain should not be assumed for other strains without separate studies.[5] Whether multi-strain products work better than single-strain ones is not settled. A 2011 review found only 16 studies that compared a mixture with its component strains; the mixture was more effective in 12, but it was unclear whether this reflected interaction between strains or a higher total dose.[6]
| Strain | How it is typically described | What the evidence shows |
|---|---|---|
| Lactobacillus Acidophilus (La-14) | A common species in probiotic products, often discussed for digestive health | Effects are strain-specific. Results for one L. acidophilus strain (such as the children's trial described below) do not apply to every strain of the species or to adults |
| Bifidobacterium Lactis (Bl-04) | A common species in probiotic products, often discussed for digestive and immune health | Trials have tested specific strains; results do not automatically apply to other strains of B. lactis |
| Lactobacillus Plantarum (Lp-115) | A common species in probiotic products, often discussed for IBS and other digestive symptoms | Results vary by strain. A 2018 meta-analysis of IBS trials found that particular combinations or strains appeared to help symptoms and abdominal pain, but firm conclusions could not be drawn[7] |
| Lactobacillus Paracasei (Lpc-37) | A species used in some probiotic products, often discussed for immune health | Strain-specific. No strain-level evidence for cold and flu outcomes is reviewed here |
Matching a product to published studies requires the full strain designation (usually a letter-and-number code after the species name) and the dose of each strain. The table above lists species names only. Check the product label for strain codes, and treat claims about where in the gut particular species act, or about strains complementing each other, as unproven unless they are backed by strain-level studies.
Prebiotics and Synbiotics
A prebiotic is a substance, usually a type of fiber, that gut microbes can use as food. Fructooligosaccharides (FOS) is the prebiotic included in this formula. Prebiotic fibers such as FOS and inulin can cause gas and bloating in some people, particularly at higher intakes, and tolerance differs between fiber types.[8]
A product that combines live probiotics with a prebiotic is called a synbiotic. An expert panel defined a synbiotic as a mixture of live microorganisms and substrates that are selectively used by host microorganisms and together give a health benefit.[9] Whether adding a prebiotic improves colonization or clinical outcomes has to be shown for the specific combination. In IBS trials, data for synbiotics were sparse and no firm conclusion about their efficacy could be drawn.[7]
What the Research Shows
Digestive health and IBSEvidence on probiotics in digestive health is mixed and depends on the strain and the condition. A 2018 meta-analysis by Ford et al. of 53 randomized trials of probiotics in IBS found that particular combinations of probiotics, or specific species and strains, appeared to help global symptoms and abdominal pain, but it was not possible to draw definitive conclusions; data for prebiotics and synbiotics were sparse, and adverse events were no more common with probiotics.[7] An earlier meta-analysis by Moayyedi et al. of 19 trials reported that probiotics were better than placebo for IBS (relative risk of symptoms not improving 0.71; number needed to treat 4), but with significant heterogeneity between trials, and the authors said the size of the benefit and the most effective species and strain were uncertain.[10] The effects are strain-specific, so strain-level evidence matters as well as the total CFU count.
Antibiotic-associated diarrheaAntibiotics disturb the gut microbiome and can cause diarrhea, and in some people they reduce resistance to infections such as C. difficile. A meta-analysis in JAMA by Hempel et al. identified 82 randomized controlled trials; pooling 63 of them (11,811 participants), probiotic use was associated with a lower risk of antibiotic-associated diarrhea (RR 0.58; 95% CI 0.50–0.68). The authors noted significant heterogeneity, poorly documented strains, and insufficient evidence to say whether the effect varies by population, antibiotic or probiotic preparation.[11] A 2025 Cochrane update of 47 trials found that, across the 38 trials that reported it, probiotics may reduce C. difficile-associated diarrhea by about half (RR 0.50; low-certainty evidence), roughly one case prevented for every 65 people taking probiotics. It also concluded that short-term use is likely not associated with adverse effects in people receiving antibiotics who are not immunocompromised. Authors of 28 of the included studies were affiliated with, or funded by, probiotic companies.[12] We did not find a verified source showing that the timing of the first probiotic dose, or its spacing from the antibiotic dose, changes the result. Take antibiotics exactly as prescribed, and ask your pharmacist or prescriber whether and when to take a probiotic.
Immune functionThe gut and the immune system interact, but this does not by itself show that a probiotic supplement prevents infections. One double-blind, placebo-controlled trial published in Pediatrics, by Leyer et al., enrolled 326 healthy children aged 3–5 years who received L. acidophilus NCFM alone or combined with B. animalis subsp. lactis Bi-07 twice daily for 6 months. Relative to placebo, the single strain and the combination reduced fever incidence by 53.0% and 72.7%, coughing incidence by 41.4% and 62.1%, and antibiotic use by 68.4% and 84.2%.[13] This trial tested specific strains in young children; its results cannot be assumed for adults or for other strains.
Metabolic healthThe gut microbiome is thought to interact with metabolism through several pathways, including short-chain fatty acid production, bile acid metabolism and inflammatory signaling. A review by Gomes et al. described animal and human research suggesting that probiotics may reduce inflammation and oxidative stress and increase expression of intestinal adhesion proteins, which could affect insulin sensitivity, but the authors said further investigation is needed to clarify whether probiotics can be used to prevent or manage diabetes.[14] A 2026 umbrella review of 128 systematic reviews reported improved blood sugar control, lipid profiles and inflammation with certain probiotics in people with type 2 diabetes, but effects varied by strain, population and condition.[15] These findings do not show that a probiotic supplement treats or prevents a metabolic condition. People with diabetes or prediabetes should discuss supplements with their clinician, particularly if they take glucose-lowering medicines.
Common Reasons People Consider Probiotics
- Frequent bloating or gas
- Irregular bowel movements
- Recurring digestive discomfort
- Recent antibiotic course
- Frequent colds or low immunity
- High sugar or processed food diet
- Mood dips or low energy
- Poor sleep quality
- GLP-1 medication side effects
- Low-fiber diet
- Chronic stress
- Food sensitivities developing
These signs have many possible causes and do not show that your gut microbiome needs support or that a probiotic will help. Persistent or worsening digestive symptoms, blood in the stool, unexplained weight loss or fever should be assessed by a clinician.
Who Might Consider Probiotics
Alongside antibiotics
Pooled trials associate probiotic use with a lower risk of antibiotic-associated diarrhea, although the Cochrane review rates the certainty of that evidence as low and results depend on the strain.[11][12] Whether continuing a probiotic after the antibiotic course speeds recovery of the gut microbiome is not established: in one study in people and mice, probiotics delayed the return of the normal gut microbiome after antibiotics.[16] Take antibiotics exactly as prescribed, and ask your pharmacist or prescriber about probiotics, especially if your immune system is weakened.
People with IBS or digestive discomfort
Trials of probiotics in IBS have given mixed results, and which species and strains work is unclear.[7][10] If you have chronic bloating, variable stool consistency or abdominal pain, see a clinician to find the cause before trying supplements, especially if you have blood in the stool, unexplained weight loss or symptoms that keep getting worse.
Mood and stress support
The gut contains much of the body's serotonin, and in mice gut bacteria influence its production.[17] A 2026 meta-analysis of 12 randomized trials in 3,350 healthy working adults found a small effect of probiotics on symptoms of depression, anxiety and stress, which the authors called preliminary; results varied with strain, dose and duration.[18] Probiotics are not a treatment for depression or anxiety. If you have persistent low mood or anxiety, talk to a clinician.
GLP-1 medication users
GLP-1 medicines such as semaglutide can delay gastric emptying and commonly cause digestive side effects such as nausea, vomiting, diarrhea and constipation, usually around the start of treatment and dose increases.[19] We did not find studies of probiotic safety or benefit specifically in people taking these medicines, so no claim is made either way. If you take a GLP-1 medicine, talk to your prescriber or pharmacist before adding a probiotic or any other supplement.
Plant-based eaters
Fermented foods common in omnivore diets (yogurt, kefir) contain live cultures that plant-based eaters may miss unless they eat fermented plant foods. A supplement is one option but is not required for health, and it does not replace a varied, fiber-rich diet. The FOS prebiotic in this formula is entirely plant-derived.
Adults over 50
Gut microbiome composition is reported to shift with age.[20] Whether probiotic supplements change health outcomes in older adults has not been established, and a 2026 review of long-term trials in at-risk populations (such as older, immunocompromised and gastrointestinal patients) concluded that the evidence does not permit conclusions about long-term safety.[21] Older adults with a serious illness, a central venous catheter or reduced immunity should check with a doctor before using probiotics.
Probiotics are live organisms. In healthy adults they are generally well tolerated, and the most commonly reported effects are digestive, such as cramping, gas, bloating and loose stools.[22][12] Long-term safety data are limited: a 2026 review of long-term trials in at-risk groups concluded that adverse-event reporting was too inconsistent to draw conclusions about long-term safety.[21]
Rare but serious infections of the bloodstream (bacteremia or sepsis) have been reported with probiotic organisms, mostly in people who are seriously ill, have a weakened immune system or have a central venous catheter.[22][23][24] In a trial of 2,653 critically ill adults on ventilators, 15 people (1.1%) given Lactobacillus rhamnosus GG had that organism in a normally sterile site, or as the sole or predominant organism in a non-sterile site, compared with 1 (0.1%) given placebo.[25] In a trial of 298 people with predicted severe acute pancreatitis, a multispecies probiotic was associated with higher mortality (16% vs 6%), and the authors advised against its use in that group.[26] The American Academy of Pediatrics has concluded that current evidence does not support routine use of probiotics in preterm infants, particularly those under 1,000 g.[27] In a narrative review of probiotics and related products in children with short bowel syndrome, serious events including Lactobacillus sepsis and D-lactic acidosis were reported, mostly in people with central venous catheters or malabsorption.[28]
Talk to a doctor before taking a probiotic if you have a weakened immune system (for example after an organ transplant or during chemotherapy), a central venous catheter, a serious illness or a hospital stay, pancreatitis or short bowel syndrome, or if you are pregnant or breastfeeding. Do not give probiotics to a premature infant unless a neonatal clinician advises it. If you develop a fever, chills or other signs of infection while taking a probiotic, seek medical care. This article is general information and does not replace advice from your own clinician or pharmacist.
40 Billion CFU + Prebiotics
4 strains (La-14, Bl-04, Lp-115, Lpc-37). 40 billion CFU per 2-capsule serving. Contains MAKTREK® Bi-Pass Technology and an FOS prebiotic. Third-party tested, GMP certified.
The Gut Support Stack
Probiotics are live microorganisms. Digestive enzymes are a different type of product with their own evidence base, which this article does not review. Persistent digestive discomfort, poor nutrient absorption or digestive side effects from medicines are worth discussing with a clinician or pharmacist before trying combinations of supplements.
How to Compare Probiotic Products
| What to check | What it means | Green flag | Red flag |
|---|---|---|---|
| CFU count | Viable bacteria count at manufacture | Count given for each strain, with the amount used in studies of that strain | A high total number with no strain detail; a higher number is not by itself a better product |
| Delivery protection | How probiotics survive stomach acid | Survival data for the specific strains and formulation (acid and bile tolerance, stability testing), not only a description of the capsule | Claims such as "protected" or "live delivery" with no survival data |
| Strain specificity | Which strains are listed by full name | Full genus, species, and ideally strain code listed | Just says "Lactobacillus blend" with no strain detail |
| CFU guarantee | When the CFU is measured | "Guaranteed through expiry" or "at time of use" | "At time of manufacture" only |
| Prebiotic inclusion | Fuel for probiotic bacteria | If a prebiotic is included, its type and amount are listed (fibers such as inulin and FOS can cause gas and bloating in some people) | Claims that a prebiotic makes the probiotic "settle in" with no data for that combination |
| Third-party testing | Independent verification of claims | NSF International, USP, or Informed Sport certified | Self-certified, no third-party verification mentioned |
Common Misunderstandings — Cleared Up
Questions People Ask
Taking probiotics with a meal is common advice, but the best timing depends on the strain and formulation, so follow the directions on the product label. The Kasivit Probiotic label lists a serving as 2 capsules.
Responses vary, and some people notice no change. Whether a probiotic helps depends on the strain and the reason for taking it, and for many conditions it is unclear which strains work.[7] If digestive symptoms persist or worsen, or new symptoms appear, talk to a clinician.
Probiotics are generally well tolerated in healthy adults, and mild digestive effects such as gas, bloating or loose stools are the most commonly reported.[22] Long-term safety data are limited: a 2026 review of long-term trials in at-risk groups found that adverse-event reporting was inconsistent and that rare or strain-specific harms could not be assessed.[21] People with a weakened immune system, a central venous catheter, a serious illness or a serious bowel condition should not take probiotics without medical advice (see the box above). The prebiotic fiber added to some products, such as inulin or FOS, can also cause gas and bloating in some people.[8]
For most people without a weakened immune system, short-term probiotic use alongside antibiotics was not associated with extra adverse effects in a large Cochrane review.[12] Take your antibiotic exactly as prescribed, and ask your pharmacist or prescriber whether and when to take a probiotic relative to your doses. If you are immunocompromised, check with your doctor first.
The manufacturer describes it as a protective matrix intended to help the bacteria survive stomach acid. We did not find published studies of this technology, so no survival data for the product is cited here. Check the label and strain-level studies, and do not assume that a delivery technology guarantees that a given number of live bacteria reaches the gut.
If you take a GLP-1 medicine, talk to your prescriber or pharmacist before adding a probiotic or any other supplement. GLP-1 medicines can delay gastric emptying and commonly cause digestive side effects such as nausea, vomiting, diarrhea and constipation, usually around the start of treatment and dose increases.[19] We did not find studies of probiotic safety or benefit specifically in people taking these medicines, so no claim is made either way.
CFU count is only one number on a probiotic label, and it is often measured at manufacture rather than at expiry. Other things to check are whether the strains are named in full, including strain codes; whether the amount per strain matches what was used in studies of that strain; and whether survival through digestion and storage has been shown for that product rather than only claimed.[1][2] Strain selection matters because effects are strain-specific.[5] The Kasivit Probiotic uses MAKTrek® Bi-Pass Technology, four strains and an FOS prebiotic. As with any product, check the label and strain-level studies for survival data, and talk to a clinician before use if you have a weakened immune system, a central venous catheter or a serious illness.
References
- 1 Cook MT, et al. J Control Release. 2012;162(1):56-67. PubMed · DOI
- 2 Brousilova T, et al. Front Nutr. 2026;13:1933900. PubMed · DOI
- 3 Hill C, et al. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. PubMed · DOI
- 4 Aziz G, et al. Probiotics Antimicrob Proteins. 2022;14(2):288-312. PubMed · DOI
- 5 Boyle RJ, et al. Am J Clin Nutr. 2006;83(6):1256-64. PubMed · DOI
- 6 Chapman CM, et al. Eur J Nutr. 2011;50(1):1-17. PubMed · DOI
- 7 Ford AC, et al. Aliment Pharmacol Ther. 2018;48(10):1044-1060. PubMed · DOI
- 8 Mysonhimer AR, Holscher HD. Adv Nutr. 2022;13(6):2237-2276. PubMed · DOI
- 9 Swanson KS, et al. Nat Rev Gastroenterol Hepatol. 2020;17(11):687-701. PubMed · DOI
- 10 Moayyedi P, et al. Gut. 2010;59(3):325-32. PubMed · DOI
- 11 Hempel S, et al. JAMA. 2012;307(18):1959-69. PubMed · DOI
- 12 Esmaeilinezhad Z, et al. Cochrane Database Syst Rev. 2025;9(9):CD006095. PubMed · DOI
- 13 Leyer GJ, et al. Pediatrics. 2009;124(2):e172-9. PubMed · DOI
- 14 Gomes AC, et al. Nutr J. 2014;13:60. PubMed · DOI
- 15 Hoang T, Kim J. Nutr Rev. 2026 Jun 15:nuaf303 (online ahead of print). PubMed · DOI
- 16 Suez J, et al. Cell. 2018;174(6):1406-1423.e16. PubMed · DOI
- 17 Yano JM, et al. Cell. 2015;161(2):264-76. PubMed · DOI
- 18 Ben Fredj S, et al. BMC Psychol. 2026;14(1):175. PubMed · DOI
- 19 Singhani V, et al. Nutr Clin Pract. 2026;41(5):1318-1333. PubMed · DOI
- 20 Todmal TG, et al. Geriatrics (Basel). 2026;11(4):107. PubMed · DOI
- 21 Alshatari S, Ziarno M. Front Nutr. 2026;13:1895136. PubMed · DOI
- 22 Doron S, Snydman DR. Clin Infect Dis. 2015;60(Suppl 2):S129-34. PubMed · DOI
- 23 Kullar R, et al. Microorganisms. 2023;11(4):896. PubMed · DOI
- 24 Land MH, et al. Pediatrics. 2005;115(1):178-81. PubMed · DOI
- 25 Johnstone J, et al. JAMA. 2021;326(11):1024-1033. PubMed · DOI
- 26 Besselink MG, et al. Lancet. 2008;371(9613):651-659. PubMed · DOI
- 27 Poindexter B, Committee on Fetus and Newborn. Pediatrics. 2021;147(6):e2021051485. PubMed · DOI
- 28 Ruiz RG, et al. Children (Basel). 2026;13(3):349. PubMed · DOI
